Cryo-EM structures of CCHFV polymerase reveal a stepwise initiation stabilization pathway and a dual-site inhibition mechanism
Abstract
Crimean-Congo hemorrhagic fever virus (CCHFV) is a high-priority pathogen with high case-fatality rates, yet approved therapeutics remain unavailable. The CCHFV L segment encodes a ~450-kDa RNA-dependent RNA polymerase (L protein) orchestrating viral replication, but its structural mechanisms remain elusive. Here, we present high-resolution cryo-EM structures of the CCHFV L protein in apo, 5' vRNA-bound, 5'/3' promoter-bound, and inhibitor-bound states. The catalytic core exhibits the canonical architecture of the Bunyavirales order, featuring conserved motifs and coordinated promoter recognition via a 5' vRNA "hook" and a secondary 3' vRNA-binding site. Using suramin as a probe, we identified a dual-site mechanism of polymerase inhibition. Suramin competitively occludes the 5' vRNA-binding pocket through electrostatic mimicry of the RNA backbone and concurrently traps a distal Linker–Fingers interface, restricting the conformational dynamics required for catalysis. Collectively, these findings provide structural insights into CCHFV polymerase regulation and inhibition.
References
1. McFadden, E., Monticelli, S.R., Wang, A., Ramamohan, A.R., Batchelor, T.G., Kuehne, A.I., Bakken, R.R., Tse, A.L., Chandran, K., Herbert, A.S., and McLellan, J.S. (2025). Engineering and structures of Crimean-Congo hemorrhagic fever virus glycoprotein complexes. Cell 188, 303–315 e313. 10.1016/j.cell.2024.11.008.
2. Ritter, M., Canus, L., Gautam, A., Vallet, T., Zhong, L., Lalande, A., Boson, B., Gandhi, A., Bodoirat, S., Burlaud-Gaillard, J., et al. (2024). The low-density lipoprotein receptor and apolipoprotein E associated with CCHFV particles mediate CCHFV entry into cells. Nat Commun 15, 4542. 10.1038/s41467-024-48989-5.
3. Monteil, V.M., Wright, S.C., Dyczynski, M., Kellner, M.J., Appelberg, S., Platzer, S.W., Ibrahim, A., Kwon, H., Pittarokoilis, I., Mirandola, M., et al. (2024). Crimean-Congo haemorrhagic fever virus uses LDLR to bind and enter host cells. Nat Microbiol 9, 1499–1512. 10.1038/s41564-024-01672-3.
4. Golden, J.W., Shoemaker, C.J., Lindquist, M.E., Zeng, X., Daye, S.P., Williams, J.A., Liu, J., Coffin, K.M., Olschner, S., Flusin, O., et al. (2019). GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Sci Adv 5, eaaw9535. 10.1126/sciadv.aaw9535.
5. Hawman, D.W., and Feldmann, H. (2023). Crimean-Congo haemorrhagic fever virus. Nat Rev Microbiol 21, 463–477. 10.1038/s41579-023-00871-9.
6. Frank, M.G., Weaver, G., Raabe, V., State of the Clinical Science Working Group of the National Emerging Pathogens, T., Education Center's Special Pathogens Research, N., and State of the Clinical Science Working Group of the National Emerging Pathogens Training Education Center's Special Pathogens Research, N. (2024). Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Diagnosis, Clinical Management, and Therapeutics. Emerg Infect Dis 30, 864–873. 10.3201/eid3005.231648.
7. Bente, D.A., Forrester, N.L., Watts, D.M., McAuley, A.J., Whitehouse, C.A., and Bray, M. (2013). Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 100, 159–189. 10.1016/j.antiviral.2013.07.006.
8. WHO (2018). 2018 Annual review of diseases prioritized under the Research and Development Blueprint. World Health Organization Geneva, Switzerland.
9. Ma, J., Lv, X.L., Zhang, X., Han, S.Z., Wang, Z.D., Li, L., Sun, H.T., Ma, L.X., Cheng, Z.L., Shao, J.W., et al. (2021). Identification of a new orthonairovirus associated with human febrile illness in China. Nat Med 27, 434–439. 10.1038/s41591-020-01228-y.
10. Zhang, X.A., Ma, Y.D., Zhang, Y.F., Hu, Z.Y., Zhang, J.T., Han, S., Wang, G., Li, S., Wang, X., Tang, F., et al. (2024). A New Orthonairovirus Associated with Human Febrile Illness. N Engl J Med 391, 821–831. 10.1056/NEJMoa2313722.
11. Zhang, M.Z., Bian, C., Ye, R.Z., Cui, X.M., Chu, Y.L., Yao, N.N., Xu, X.W., Ye, J.L., Chen, L., Yang, J.H., et al. (2025). Human Infection with a Novel Tickborne Orthonairovirus Species in China. N Engl J Med 392, 200–202. 10.1056/NEJMc2410853.
12. Iglesias-Rivas, P., Gonzalez-Vazquez, L.D., and Arenas, M. (2025). Molecular Evolution and Phylogeography of the Crimean-Congo Hemorrhagic Fever Virus. Viruses 17. 10.3390/v17081054.
13. Zivcec, M., Scholte, F.E., Spiropoulou, C.F., Spengler, J.R., and Bergeron, E. (2016). Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus. Viruses 8, 106. 10.3390/v8040106.
14. Kuang, W., Tian, Z., Zhang, G., Wu, F., Li, J., Tang, J., Zhang, H., Zhuo, X., Hu, Z., Wang, M., et al. (2026). Structure and function of the nairovirus cap-snatching endonuclease. Nucleic Acids Res 54. 10.1093/nar/gkaf1515.
15. Leventhal, S.S., Bisom, T., Clift, D., Rao, D., Meade-White, K., Shaia, C., Murray, J., Mihalakakos, E.A., Hinkley, T., Reynolds, S.J., et al. (2024). Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21. Nat Commun 15, 9236. 10.1038/s41467-024-53362-7.
16. Akutsu, M., Ye, Y., Virdee, S., Chin, J.W., and Komander, D. (2011). Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc Natl Acad Sci U S A 108, 2228–2233. 10.1073/pnas.1015287108.
17. Spengler, J.R., Patel, J.R., Chakrabarti, A.K., Zivcec, M., Garcia-Sastre, A., Spiropoulou, C.F., and Bergeron, E. (2015). RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus. J Virol 89, 10219–10229. 10.1128/JVI.01643-15.
18. Scholte, F.E.M., Zivcec, M., Dzimianski, J.V., Deaton, M.K., Spengler, J.R., Welch, S.R., Nichol, S.T., Pegan, S.D., Spiropoulou, C.F., and Bergeron, E. (2017). Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease. Cell Rep 20, 2396–2407. 10.1016/j.celrep.2017.08.040.
19. Peng, R., Xu, X., Jing, J., Wang, M., Peng, Q., Liu, S., Wu, Y., Bao, X., Wang, P., Qi, J., et al. (2020). Structural insight into arenavirus replication machinery. Nature 579, 615–619. 10.1038/s41586-020-2114-2.
20. Xu, X., Peng, R., Peng, Q., Wang, M., Xu, Y., Liu, S., Tian, X., Deng, H., Tong, Y., Hu, X., et al. (2021). Cryo-EM structures of Lassa and Machupo virus polymerases complexed with cognate regulatory Z proteins identify targets for antivirals. Nat Microbiol 6, 921–931. 10.1038/s41564-021-00916-w.
21. Ma, J., Zhang, S., and Zhang, X. (2021). Structure of Machupo virus polymerase in complex with matrix protein Z. Nat Commun 12, 6163. 10.1038/s41467-021-26432-3.
22. Kouba, T., Vogel, D., Thorkelsson, S.R., Quemin, E.R.J., Williams, H.M., Milewski, M., Busch, C., Gunther, S., Grunewald, K., Rosenthal, M., and Cusack, S. (2021). Conformational changes in Lassa virus L protein associated with promoter binding and RNA synthesis activity. Nat Commun 12, 7018. 10.1038/s41467-021-27305-5.
23. Durieux Trouilleton, Q., Barata-Garcia, S., Arragain, B., Reguera, J., and Malet, H. (2023). Structures of active Hantaan virus polymerase uncover the mechanisms of Hantaviridae genome replication. Nat Commun 14, 2954. 10.1038/s41467-023-38555-w.
24. Durieux Trouilleton, Q., Housset, D., Tarillon, P., Arragain, B., and Malet, H. (2024). Structural characterization of the oligomerization of full-length Hantaan virus polymerase into symmetric dimers and hexamers. Nat Commun 15, 2256. 10.1038/s41467-024-46601-4.
25. Keown, J.R., Carrique, L., Nilsson-Payant, B.E., Fodor, E., and Grimes, J.M. (2024). Structural characterization of the full-length Hantaan virus polymerase. PLoS Pathog 20, e1012781. 10.1371/journal.ppat.1012781.
26. Meier, K., Thorkelsson, S.R., Durieux Trouilleton, Q., Vogel, D., Yu, D., Kosinski, J., Cusack, S., Malet, H., Grunewald, K., Quemin, E.R.J., and Rosenthal, M. (2023). Structural and functional characterization of the Sin Nombre virus L protein. PLoS Pathog 19, e1011533. 10.1371/journal.ppat.1011533.
27. Gerlach, P., Malet, H., Cusack, S., and Reguera, J. (2015). Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter. Cell 161, 1267–1279. 10.1016/j.cell.2015.05.006.
28. Arragain, B., Effantin, G., Gerlach, P., Reguera, J., Schoehn, G., Cusack, S., and Malet, H. (2020). Pre-initiation and elongation structures of full-length La Crosse virus polymerase reveal functionally important conformational changes. Nat Commun 11, 3590. 10.1038/s41467-020-17349-4.
29. Arragain, B., Durieux Trouilleton, Q., Baudin, F., Provaznik, J., Azevedo, N., Cusack, S., Schoehn, G., and Malet, H. (2022). Structural snapshots of La Crosse virus polymerase reveal the mechanisms underlying Peribunyaviridae replication and transcription. Nat Commun 13, 902. 10.1038/s41467-022-28428-z.
30. Wang, P., Liu, L., Liu, A., Yan, L., He, Y., Shen, S., Hu, M., Guo, Y., Liu, H., Liu, C., et al. (2020). Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation. Nat Microbiol 5, 864–871. 10.1038/s41564-020-0712-2.
31. Vogel, D., Thorkelsson, S.R., Quemin, E.R.J., Meier, K., Kouba, T., Gogrefe, N., Busch, C., Reindl, S., Gunther, S., Cusack, S., et al. (2020). Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein. Nucleic Acids Res 48, 5749–5765. 10.1093/nar/gkaa253.
32. Williams, H.M., Thorkelsson, S.R., Vogel, D., Milewski, M., Busch, C., Cusack, S., Grunewald, K., Quemin, E.R.J., and Rosenthal, M. (2023). Structural insights into viral genome replication by the severe fever with thrombocytopenia syndrome virus L protein. Nucleic Acids Res 51, 1424–1442. 10.1093/nar/gkac1249.
33. Wang, X., Hu, C., Ye, W., Wang, J., Dong, X., Xu, J., Li, X., Zhang, M., Lu, H., Zhang, F., et al. (2022). Structure of Rift Valley Fever Virus RNA-Dependent RNA Polymerase. J Virol 96, e0171321. 10.1128/JVI.01713-21.
34. Li, J., Cao, L., Zhao, Y., Shen, J., Wang, L., Feng, M., Zhu, M., Ye, Y., Kormelink, R., Tao, X., and Wang, X. (2025). Structural basis for the activation of plant bunyavirus replication machinery and its dual-targeted inhibition by ribavirin. Nat Plants 11, 518–530. 10.1038/s41477-025-01940-y.
35. Wang, D., Yang, G., and Liu, B. (2026). Structure of Crimean-Congo haemorrhagic fever virus RNA polymerase. Nat Microbiol 11, 1711–1721. 10.1038/s41564-026-02319-1.
36. Deng, A., Cunnison, R., Carrique, L., Gunl, F., Pardon, E., Steyaert, J., Duc, D.N., Grimes, J.M., Robb, N., and Keown, J.R. (2026). Structural and functional characterisation of the Crimean-Congo haemorrhagic fever virus RNA dependent RNA polymerase. Nat Commun. 10.1038/s41467-026-74113-w.
37. Jacques, J.-P., and Kolakofsky, D. (1991). Pseudo-templated transcription in prokaryotic and eukaryotic organisms. Genes & development 5, 707–713.
38. CT, R.-K., and Cheng Kao, C. (2006). Biochemical Activities of the HCV NS5B RNA-Dependent RNA Polymerase. Tan SL (Hg.): Hepatitis C Viruses: Genomes and Molecular Biology. Kapitel 10.
39. Capodagli, G.C., McKercher, M.A., Baker, E.A., Masters, E.M., Brunzelle, J.S., and Pegan, S.D. (2011). Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J Virol 85, 3621–3630. 10.1128/JVI.02496-10.
40. James, T.W., Frias-Staheli, N., Bacik, J.P., Levingston Macleod, J.M., Khajehpour, M., Garcia-Sastre, A., and Mark, B.L. (2011). Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc Natl Acad Sci U S A 108, 2222–2227. 10.1073/pnas.1013388108.
41. Pflug, A., Guilligay, D., Reich, S., and Cusack, S. (2014). Structure of influenza A polymerase bound to the viral RNA promoter. Nature 516, 355–360. 10.1038/nature14008.
42. Reich, S., Guilligay, D., Pflug, A., Malet, H., Berger, I., Crepin, T., Hart, D., Lunardi, T., Nanao, M., Ruigrok, R.W., and Cusack, S. (2014). Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516, 361–366. 10.1038/nature14009.
43. Te Velthuis, A.J., and Fodor, E. (2016). Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol 14, 479–493. 10.1038/nrmicro.2016.87.
44. Te Velthuis, A.J.W., Grimes, J.M., and Fodor, E. (2021). Structural insights into RNA polymerases of negative-sense RNA viruses. Nat Rev Microbiol 19, 303–318. 10.1038/s41579-020-00501-8.
45. Gucwa, M., Bijak, V., Zheng, H., Murzyn, K., and Minor, W. (2024). CheckMyMetal (CMM): validating metal-binding sites in X-ray and cryo-EM data. IUCrJ 11, 871–877. 10.1107/S2052252524007073.
46. Yuan, B., Peng, Q., Cheng, J., Wang, M., Zhong, J., Qi, J., Gao, G.F., and Shi, Y. (2022). Structure of the Ebola virus polymerase complex. Nature 610, 394–401. 10.1038/s41586-022-05271-2.
47. Yin, W., Luan, X., Li, Z., Zhou, Z., Wang, Q., Gao, M., Wang, X., Zhou, F., Shi, J., You, E., et al. (2021). Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Nat Struct Mol Biol 28, 319–325. 10.1038/s41594-021-00570-0.
48. Mastrangelo, E., Pezzullo, M., Tarantino, D., Petazzi, R., Germani, F., Kramer, D., Robel, I., Rohayem, J., Bolognesi, M., and Milani, M. (2012). Structure-based inhibition of Norovirus RNA-dependent RNA polymerases. J Mol Biol 419, 198–210. 10.1016/j.jmb.2012.03.008.
49. Jiao, L., Ouyang, S., Liang, M., Niu, F., Shaw, N., Wu, W., Ding, W., Jin, C., Peng, Y., Zhu, Y., et al. (2013). Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential. J Virol 87, 6829–6839. 10.1128/JVI.00672-13.
50. Ellenbecker, M., Lanchy, J.M., and Lodmell, J.S. (2014). Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin. Antimicrob Agents Chemother 58, 7405–7415. 10.1128/AAC.03595-14.
51. Boehr, D.D., Nussinov, R., and Wright, P.E. (2009). The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 5, 789–796. 10.1038/nchembio.232.
52. Johnson, S., Henschke, N., Maayan, N., Mills, I., Buckley, B.S., Kakourou, A., and Marshall, R. (2018). Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database Syst Rev 6, CD012713. 10.1002/14651858.CD012713.pub2.
53. Ascioglu, S., Leblebicioglu, H., Vahaboglu, H., and Chan, K.A. (2011). Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 66, 1215–1222. 10.1093/jac/dkr136.
54. Hawman, D.W., Haddock, E., Meade-White, K., Nardone, G., Feldmann, F., Hanley, P.W., Lovaglio, J., Scott, D., Komeno, T., Nakajima, N., et al. (2020). Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antiviral Res 181, 104858. 10.1016/j.antiviral.2020.104858.
55. Tipih, T., Meade-White, K., Rao, D., Bushmaker, T., Lewis, M., Shaia, C., Feldmann, H., and Hawman, D.W. (2023). Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection. Antiviral Res 218, 105703. 10.1016/j.antiviral.2023.105703.
56. Hawman, D.W., Haddock, E., Meade-White, K., Williamson, B., Hanley, P.W., Rosenke, K., Komeno, T., Furuta, Y., Gowen, B.B., and Feldmann, H. (2018). Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Res 157, 18–26. 10.1016/j.antiviral.2018.06.013.
57. Ji, X., Jiang, X., Huang, X., Gao, H., Gao, Z., Gao, P., De Clercq, E., Pannecouque, C., Kang, D., Zhan, P., and Liu, X. (2025). Design, synthesis, and biological evaluation of dual-site HIV-1 inhibitors simultaneously targeting the NNRTI binding pocket and an adjacent site with favorable resistance profiles. Bioorg Chem 164, 108924. 10.1016/j.bioorg.2025.108924.
58. Pettersen, E.F., Goddard, T.D., Huang, C.C., Meng, E.C., Couch, G.S., Croll, T.I., Morris, J.H., and Ferrin, T.E. (2021). UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci 30, 70–82. 10.1002/pro.3943.
59. Punjani, A., Rubinstein, J.L., Fleet, D.J., and Brubaker, M.A. (2017). cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290–296. 10.1038/nmeth.4169.
60. Casanal, A., Lohkamp, B., and Emsley, P. (2020). Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data. Protein Sci 29, 1069–1078. 10.1002/pro.3791.
61. Afonine, P.V., Poon, B.K., Read, R.J., Sobolev, O.V., Terwilliger, T.C., Urzhumtsev, A., and Adams, P.D. (2018). Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D Struct Biol 74, 531–544. 10.1107/S2059798318006551.
62. Abramson, J., Adler, J., Dunger, J., Evans, R., Green, T., Pritzel, A., Ronneberger, O., Willmore, L., Ballard, A.J., Bambrick, J., et al. (2024). Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500. 10.1038/s41586-024-07487-w.
Metrics
DOI:
Submission ID:
Downloads
Posted
Versions
- 2026-08-18 (2)
- 2026-03-07 (1)
How to Cite
Download Citation
Declaration of Competing Interests
The authors declare no competing interests to disclose.
Copyright
The copyright holder for this preprint is the author/funder.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.